Breo Ellipta (fluticasone furoate/vilanterol) Patient Assistance Program
Don’t let the high cost of brand ICS/LABA combination inhaler disrupt your asthma or COPD treatment. We help eligible patients access Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Breo Ellipta (fluticasone furoate/vilanterol) is FDA-approved for maintenance treatment of asthma in patients 5 years and older, and for maintenance treatment of airflow obstruction in COPD (chronic bronchitis and emphysema). Once-daily ICS/LABA combination — reduces asthma exacerbations, improves COPD lung function.
- Without assistance, Breo Ellipta costs commonly run approximately $400–$500 per inhaler.
- Through AffordMyPrescriptions, qualifying patients can access Breo Ellipta for a flat $69.95 per month.
- Other ICS/LABA combinations: Advair (fluticasone/salmeterol — generic Wixela and others), Symbicort (budesonide/formoterol — generic), Dulera (mometasone/formoterol — brand). Triple therapy ICS/LAMA/LABA: Trelegy Ellipta (once daily), Breztri Aerosphere (twice daily). Airsupra (budesonide/albuterol — rescue-only for asthma). Biologics for severe asthma. SMART regimen with Symbicort or Dulera.
What is Breo Ellipta Prescription Assistance Program?
The Breo Ellipta Patient Assistance Program helps eligible patients access this ICS/LABA inhaler at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Breo Ellipta PAP enrollment for a flat $69.95 per month — so you never face a gap in Breo Ellipta therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Breo Ellipta enrollment — so you never face a gap in your asthma or COPD maintenance treatment.
Pharmacy Price Comparison
- Without assistance, Breo Ellipta costs hundreds per inhaler. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Symbicort generic | ~$100/inhaler | Cheap generic ICS/LABA alt |
| Walgreens | ~$450/inhaler | Save substantially |
| CVS Pharmacy | ~$500/inhaler | Save substantially |
| Walmart | ~$420/inhaler | Save substantially |
| Costco | ~$400/inhaler | Save substantially |
| Wixela (Advair generic) | ~$100/inhaler | Cheap generic ICS/LABA alt |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Breo Ellipta — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Breo Ellipta Prescription Program?
The Breo Ellipta Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Generic ICS/LABA combinations (Wixela — Advair generic; generic Symbicort) offer significant cost savings for twice-daily dosing. Breo Ellipta’s advantage is once-daily convenience, which improves adherence.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Breo Ellipta assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Breo Ellipta is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Breo Ellipta:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $400–$500 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Breo Ellipta assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Breo Ellipta Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Breo Ellipta:
Breo Ellipta combines fluticasone furoate (ICS) with vilanterol (LABA) in a once-daily dry powder inhaler. For asthma and COPD. Once-daily convenience improves adherence vs twice-daily ICS/LABA combinations.
How It Works:
Asthma and COPD both involve airway inflammation and bronchoconstriction. ICS/LABA combinations provide two complementary mechanisms in one inhaler — reducing airway inflammation (ICS) and causing bronchodilation (LABA). This is standard-of-care for moderate-severe asthma and for COPD patients with frequent exacerbations. Fluticasone furoate is an ICS with extended pharmacokinetics enabling once-daily dosing. Vilanterol is a long-acting beta-agonist with extended duration. Combined in the Breo Ellipta once-daily dry powder inhaler. GINA guidelines emphasize ICS-containing therapy for all asthma patients; for COPD, ICS/LABA is reserved for patients with frequent exacerbations.
Form and Use:
Breo Ellipta one inhalation once daily at the same time each day. Asthma strengths: 100/25 mcg, 200/25 mcg. COPD strength: 100/25 mcg. Ellipta device. Rinse mouth after use to reduce oral candidiasis. Not for acute bronchospasm.
Generic Availability:
No generic Breo Ellipta. Other ICS/LABA combinations: Advair (fluticasone/salmeterol — generic Wixela and generic HFA, significantly cheaper; twice daily), Symbicort (budesonide/formoterol — generic — twice daily; SMART regimen), Dulera (mometasone/formoterol — brand, twice daily), AirDuo (fluticasone/salmeterol — brand and authorized generic). Triple therapy: Trelegy Ellipta (asthma and COPD once daily), Breztri Aerosphere (COPD twice daily). Airsupra (budesonide/albuterol — asthma rescue-only combo). Biologics for severe asthma: Xolair, Nucala, Fasenra, Dupixent, Tezspire.
Warnings:
Asthma-related death (boxed warning historically applied to LABA monotherapy; ICS/LABA combinations mitigate this — GINA emphasizes ICS-containing therapy), oropharyngeal candidiasis (rinse mouth), immunosuppression, hypercorticism and adrenal suppression at high doses, decreased bone mineral density (long-term), glaucoma and cataracts (long-term), cardiovascular effects (LABA — arrhythmias), tremor, hypokalemia, hyperglycemia, decreased growth velocity in children, immediate hypersensitivity reactions. Other: nasopharyngitis, upper respiratory infections, oral candidiasis, headache. Not for acute bronchospasm.
FAQ (Frequently Asked Questions)
How much does Breo Ellipta cost without insurance?
$400–$500 per inhaler at retail pharmacies. Generic ICS/LABA alternatives (Wixela Advair generic, generic Symbicort) cost $80–$130 per inhaler — significantly cheaper for twice-daily equivalent therapy.
How is Breo Ellipta different from Advair or Symbicort?
All are ICS/LABA combinations. Breo Ellipta is fluticasone furoate/vilanterol once daily. Advair (Wixela generic) is fluticasone propionate/salmeterol twice daily. Symbicort is budesonide/formoterol twice daily. Once-daily Breo Ellipta improves adherence. Symbicort and Dulera allow the SMART regimen (controller and reliever in one). Choice by prescriber and insurance.
How is Breo Ellipta different from Trelegy Ellipta?
Both are Ellipta once-daily inhalers. Breo Ellipta is ICS/LABA (dual therapy). Trelegy Ellipta adds a LAMA (umeclidinium) — triple therapy ICS/LAMA/LABA. Trelegy is for moderate-severe asthma or COPD with frequent exacerbations; Breo Ellipta for cases where dual ICS/LABA is sufficient.
Can Breo Ellipta be used for both asthma and COPD?
Yes — FDA-approved for both. Asthma strengths: 100/25 mcg and 200/25 mcg. COPD strength: 100/25 mcg only. For COPD, ICS/LABA is reserved for patients with frequent exacerbations.
Do I still need a rescue inhaler with Breo Ellipta?
Yes — keep a rescue inhaler (albuterol MDI or Airsupra budesonide/albuterol for asthma) for acute symptoms. Breo Ellipta is not for acute bronchospasm.
Take Control of Your Medication Costs
ICS/LABA combination therapy is the foundation of moderate-severe asthma and COPD care. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.